Atlas Trials

The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD)

Clinical trial NCT00145691 · COMPLETED

Trial details

NCT number
NCT00145691
Sponsor
Sykehuset Innlandet HF
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Agitation Aggression in Dementia
Start date
2005-09-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.